EcoDrugPlus

Apoptosis Regulator Bcl-2

Ensembl ID : ENSAMXG00000030527
Gene Symbol: LOC103039548
4 Cross references
146 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSAMXG00000034699
Gene Symbol: APEX1
3 Cross references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s-Type

Ensembl ID : ENSAMXG00000011736
Gene Symbol: LOC103037595
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSAMXG00000001474
Gene Symbol: ALOX5
3 Cross references
213 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSAMXG00000003107
Gene Symbol: ALOX5AP
3 Cross references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSAMXG00000018142
Gene Symbol: AVPR1A
3 Cross references
186 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSAMXG00000031282
Gene Symbol: AVPR1A
4 Cross references
129 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSAMXG00000043546
Gene Symbol: AVPR2
3 Cross references
197 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSAMXG00000003849
Gene Symbol: LOC103024192
3 Cross references
205 Possible Orthologues:

Aurora Kinase C-Like

Ensembl ID : ENSAMXG00000008069
Gene Symbol: LOC103034578
3 Cross references
233 Possible Orthologues:

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSAMXG00000001079
Gene Symbol: LOC103047240
3 Cross references
197 Possible Orthologues:

Beta-2 Adrenergic Receptor-Like

Ensembl ID : ENSAMXG00000025830
Gene Symbol: LOC103035250
3 Cross references
150 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).